Stream A: Elevating access to cancer care: Addressing inequalities in diagnosis and treatment

Stream A: Elevating access to cancer care: Addressing inequalities in diagnosis and treatment

Tuesday, May 14, 2024 1:40 PM to 2:20 PM · 40 min. (Europe/London)

Information

  • Exploring challenges in underserved communities' access to cancer care to improve patient-caregiver interactions
  • Emphasizing the benefits of diverse perspectives in decision-making processes and learn from successful empowerment initiatives
  • Discussing ways to deliver better cancer service access in resource-limited settings to improve chances for underserved communities
  • Assessing the 75% diagnosis rate at stage 1 and 2 by 2028 – how can we meet this ambition while ensuring we are making an impact in reducing inequalities in cancer?

Bristol Myers SquibbBristol Myers Squibb (BMS)About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. The company is focused on helping millions of patients around the world in disease areas such as oncology, haematology, cardiology, immunology, fibrosis and specialty medicines. Through our Research & Development organisation, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work. Within oncology, deep scientific expertise, cutting-edge capabilities and discovery platforms enables the company to look at cancer from every angle. Cancer can have a relentless grasp on many parts of a patient’s life, and Bristol Myers Squibb is committed to taking actions to address all aspects of care, from diagnosis to survivorship. As a leading company in cancer care with high hopes and goals, Bristol Myers Squibb believes that by working together with health providers and the wider cancer community, it can empower people with cancer to have a better future.